We've considered adding this "class" to our high alert medication list. Only happens very rarely, since we already have may approved "double concentrated" drips. I supposed it would be challenging to even detect how often non-standard concentrations are built.

I'm pretty concerned that a surveyor may not appreciate seeing this class on our list. Although acknowledging the risk and trying to address it may be better than ignoring it?

I don't think there's much from an automation standpoint that we could put in place to reduce risk if we did add them to our list. Maybe create a non-standard concentration IV builder for pharmacists to use that could at least generate a MAR/label warning and prompt nursing co-sign for independent check? Would appreciate your thoughts!